STAT

Sanofi announces it will work with HHS to develop coronavirus vaccine

Sanofi said it expects to have a coronavirus vaccine candidate — a prototype — to test in vitro within six months and could be ready to test the vaccine in…

The drug maker Sanofi Pasteur is entering the race to develop a vaccine to protect against the new coronavirus sweeping through China, the company announced Monday.

David Loew, Sanofi’s global head of vaccines, said the company would partner with the U.S. Biomedical Advanced Research and Development Authority — known as BARDA — to make a vaccine using the company’s recombinant DNA platform.

Loew said the company’s previous work to develop a vaccine for SARS — a cousin virus — gives it a leg up on this work.

You’re reading a preview, subscribe to read more.

More from STAT

STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Boy Dying In Pfizer Trial; AstraZeneca Yanking Covid Shot, And More
A young boy died in a clinical trial for an experimental Pfizer gene therapy for Duchenne muscular dystrophy, about a year after receiving the therapy.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About A Roche Obesity Drug, An Experimental Lilly Insulin, And More
Roche disclosed that its recently acquired experimental obesity medication helped people lose a significant amount of weight in a Phase 1 trial.
STAT2 min read
STAT+: Pharmalittle: We’re Reading About FDA Dithering On Pharma Patents, WHO Pandemic Talks, And More
When it comes to a crucial controversy over patents for drug-and-device combination products, the FDA has been MIA.

Related Books & Audiobooks